Literature DB >> 23995620

High throughput detection of antibody self-interaction by bio-layer interferometry.

Tingwan Sun1, Felicia Reid1, Yuqi Liu1, Yuan Cao1, Patricia Estep1, Claire Nauman1, Yingda Xu1.   

Abstract

Self-interaction of an antibody may lead to aggregation, low solubility or high viscosity. Rapid identification of highly developable leads remains challenging, even though progress has been made with the introduction of techniques such as self-interaction chromatography (SIC) and cross-interaction chromatography (CIC). Here, we report a high throughput method to detect antibody clone self-interaction (CSI) using bio-layer interferometry (BLI) technology. Antibodies with strong self-interaction responses in the CSI-BLI assay also show delayed retention times in SIC and CIC. This method allows hundreds of candidates to be screened in a matter of hours with minimal material consumption.

Keywords:  aggregation; bio-layer interferometry; developability; monoclonal antibody; self-interaction; solubility

Mesh:

Substances:

Year:  2013        PMID: 23995620      PMCID: PMC3896597          DOI: 10.4161/mabs.26186

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  28 in total

1.  Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography.

Authors:  Peter M Tessier; Stanley I Sandler; Abraham M Lenhoff
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

Review 2.  Engineering aggregation-resistant antibodies.

Authors:  Joseph M Perchiacca; Peter M Tessier
Journal:  Annu Rev Chem Biomol Eng       Date:  2012-03-29       Impact factor: 11.059

3.  Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Authors:  Xiaoling Wang; Satish K Singh; Sandeep Kumar
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

4.  Exploring blocking assays using Octet, ProteOn, and Biacore biosensors.

Authors:  Yasmina N Abdiche; Dan S Malashock; Alanna Pinkerton; Jaume Pons
Journal:  Anal Biochem       Date:  2008-12-07       Impact factor: 3.365

5.  Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis.

Authors:  R Blake Pepinsky; Laura Silvian; Steven A Berkowitz; Graham Farrington; Alexey Lugovskoy; Lee Walus; John Eldredge; Allan Capili; Sha Mi; Christilyn Graff; Ellen Garber
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

6.  Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Naoyuki Kishi; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2011-08-19       Impact factor: 4.200

7.  Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates.

Authors:  Shantanu V Sule; Craig D Dickinson; Jirong Lu; Chi-Kin Chow; Peter M Tessier
Journal:  Mol Pharm       Date:  2013-03-08       Impact factor: 4.939

8.  Structure-based engineering of a monoclonal antibody for improved solubility.

Authors:  Sheng-Jiun Wu; Jinquan Luo; Karyn T O'Neil; James Kang; Eilyn R Lacy; Gabriela Canziani; Audrey Baker; Maggie Huang; Qing Mike Tang; T Shantha Raju; Steven A Jacobs; Alexey Teplyakov; Gary L Gilliland; Yiqing Feng
Journal:  Protein Eng Des Sel       Date:  2010-06-11       Impact factor: 1.650

9.  Self-interaction chromatography: a tool for the study of protein-protein interactions in bioprocessing environments.

Authors:  S Y Patro; T M Przybycien
Journal:  Biotechnol Bioeng       Date:  1996-10-20       Impact factor: 4.530

10.  Solubility evaluation of murine hybridoma antibodies.

Authors:  Stacey Spencer; Deidra Bethea; T Shantha Raju; Jill Giles-Komar; Yiqing Feng
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

View more
  19 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

2.  Biophysical properties of the clinical-stage antibody landscape.

Authors:  Tushar Jain; Tingwan Sun; Stéphanie Durand; Amy Hall; Nga Rewa Houston; Juergen H Nett; Beth Sharkey; Beata Bobrowicz; Isabelle Caffry; Yao Yu; Yuan Cao; Heather Lynaugh; Michael Brown; Hemanta Baruah; Laura T Gray; Eric M Krauland; Yingda Xu; Maximiliano Vásquez; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

3.  Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry.

Authors:  Subhashchandra Naik; Ozan S Kumru; Melissa Cullom; Srivalli N Telikepalli; Elizabeth Lindboe; Taylor L Roop; Sangeeta B Joshi; Divya Amin; Phillip Gao; C Russell Middaugh; David B Volkin; Mark T Fisher
Journal:  Protein Sci       Date:  2014-07-28       Impact factor: 6.725

4.  High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Authors:  Yuqi Liu; Isabelle Caffry; Jiemin Wu; Steven B Geng; Tushar Jain; Tingwan Sun; Felicia Reid; Yuan Cao; Patricia Estep; Yao Yu; Maximiliano Vásquez; Peter M Tessier; Yingda Xu
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

5.  Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development.

Authors:  Martin Domnowski; Jan Jaehrling; Wolfgang Frieß
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

6.  Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.

Authors:  Yulei Zhang; Lina Wu; Priyanka Gupta; Alec A Desai; Matthew D Smith; Lilia A Rabia; Seth D Ludwig; Peter M Tessier
Journal:  Mol Pharm       Date:  2020-06-11       Impact factor: 4.939

Review 7.  Selecting and engineering monoclonal antibodies with drug-like specificity.

Authors:  Charles G Starr; Peter M Tessier
Journal:  Curr Opin Biotechnol       Date:  2019-02-26       Impact factor: 9.740

8.  Development of a high-throughput solubility screening assay for use in antibody discovery.

Authors:  Qing Chai; James Shih; Caroline Weldon; Samantha Phan; Bryan E Jones
Journal:  MAbs       Date:  2019-03-26       Impact factor: 5.857

Review 9.  Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions.

Authors:  Steven B Geng; Jason K Cheung; Chakravarthy Narasimhan; Mohammed Shameem; Peter M Tessier
Journal:  J Pharm Sci       Date:  2014-09-10       Impact factor: 3.534

10.  Measuring Self-Association of Antibody Lead Candidates with Dynamic Light Scattering.

Authors:  Fabian Dingfelder; Anette Henriksen; Per-Olof Wahlund; Paolo Arosio; Nikolai Lorenzen
Journal:  Methods Mol Biol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.